Endologix Acquires Pounce Thrombectomy System From Surmodics
May 20, 2026
Endologix, a privately held medical device company, announced it will acquire the Pounce Thrombectomy System from Surmodics. The FDA-cleared, fully mechanical peripheral thrombectomy platform is intended to complement Endologix’s existing vascular intervention portfolio and expand the continuum of care for patients with peripheral vascular disease.
- Buyers
- Endologix
- Targets
- Pounce Thrombectomy System
- Sellers
- Surmodics
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.